在患有非活性甲状腺相关的眼科病症的患者中,冠状腺特征
Mahsan Samadi1, Hamidreza Ghanbari1, Ali Momeni1
1Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
BMC ophthalmology
|April 25, 2025
概括
与健康个体相比,患有非活性甲状腺相关眼病症 (TAO) 的患者表现出较高的胆道血管度指数 (CVI) 和亚管胆道厚度 (SFCT). 年龄影响SFCT,但CVI显示没有明确的联系与非活性TAO的疾病因素.
科学领域:
- 眼科医生 眼科 眼科
- 血管生物学 血管生物学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 甲状腺相关眼病 (TAO) 是一种常见的自身免疫性疾病,影响轨道组织.
- 了解非活性TAO中的冠状血管变化对于疾病管理至关重要.
研究的目的:
- 在非活性TAO期间调查胆道血管系统的变化.
- 在不活跃的TAO患者中,评估胆道血管度指数 (CVI) 和底胆道厚度 (SFCT).
主要方法:
- 使用增强深度成像光学连贯性断层扫描 (EDI-OCT) 的横截面比较案例系列.
- 在37名不活跃的TAO患者的50只眼睛和141名健康对照的282只眼睛之间比较SFCT和CVI.
- 调查SFCT/CVI与临床参数 (年龄,性别,CAS,proptosis,疾病持续时间,MRD) 之间的关联.
主要成果:
- 非活性TAO患者的SFCT (409.5±152.7μm) 和CVI (0.684±0.037) 显著高于对照组 (249.3±71.2μm和0.629±0.038,分别;p<0.001).
- 在多变量分析中,年龄与SFCT (p < 0.001) 和CVI (p < 0.001) 之间的显著负相关性.
- 只有MRD2与SFCT有显著的关联 (p <0.05);对于CVI或SFCT,没有发现其他与临床参数有显著的关联.
结论:
- 升高的SFCT和CVI是不活跃TAO的特征.
- 年龄显著影响SFCT,而CVI在非活性TAO中看起来独立于年龄和临床参数.
- 在TAO中胸膜重塑是复杂的和多因素的,需要进一步研究潜在的机制和临床影响.
更多相关视频
08:55Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
3.0K
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.0K
相关概念视频
01:25Glaucoma: Overview
470
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
470
01:27Open Angle Glaucoma: Treatment
358
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
358